Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COVID-19 Or Co-Pays: Which Is More Complex?

Executive Summary

One of many unresolved issues for the next round of COVID-19 response legislation in the US is whether and how to assure that an eventual vaccine is affordable for all Americans. The House wants to make it free to everyone – which is a lot harder than it sounds.

You may also be interested in...

Senate Republicans Pledge To Build Up Stockpiles Of COVID-19 Diagnostics, Supplies, Under HEALS Act

One of eight legislative bills put out by GOP senators under the umbrella of the HEALS Act coronavirus relief package on 27 July would build up stockpiles of diagnostics and medical supplies.

'Price Gouging’ Would Be Monitored By COVID-19 Medical Supplies Coordinator Under US House Bill

Legislation also provides the US Biomedical Advanced Research and Development Authority with $3.5bn to advance research and development, manufacturing, production and the purchase of vaccines and therapeutics.

Virtual Advisory Committees: US FDA Clears A Big Test With OxyContin Meeting

Meeting to address opioid abuse crisis was also a trial of whether FDA could conduct important public business using online-only technology.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts